Medtronic (NYSE:MDT) is scheduled to announce Q3 earnings results on Tuesday, February 18th, before market open.
The consensus EPS Estimate is $1.38 (+7.0% Y/Y) and the consensus Revenue Estimate is $7.8B (+3.3% Y/Y).
Over the last 2 years, MDT has beaten EPS estimates 88% of the time and has beaten revenue estimates 100% of the time.
Over the last 3 months, EPS estimates have seen 5 upward revisions and 12 downward. Revenue estimates have seen 7 upward revisions and 9 downward.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.